209 related articles for article (PubMed ID: 1510369)
21. Mitochondrial DNA in Parkinson's disease.
Schapira AH
Adv Neurol; 1999; 80():233-7. PubMed ID: 10410727
[No Abstract] [Full Text] [Related]
22. Human mitochondrial complex I dysfunction.
Cooper JM; Mann VM; Krige D; Schapira AH
Biochim Biophys Acta; 1992 Jul; 1101(2):198-203. PubMed ID: 1633185
[TBL] [Abstract][Full Text] [Related]
23. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.
Li H; Dryhurst G
J Neurochem; 1997 Oct; 69(4):1530-41. PubMed ID: 9326282
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
25. Novel mitochondrial DNA mutations in Parkinson's disease.
Richter G; Sonnenschein A; Grünewald T; Reichmann H; Janetzky B
J Neural Transm (Vienna); 2002 May; 109(5-6):721-9. PubMed ID: 12111463
[TBL] [Abstract][Full Text] [Related]
26. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
Li H; Shen XM; Dryhurst G
J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
[TBL] [Abstract][Full Text] [Related]
27. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.
Reichmann H; Janetzky B; Bischof F; Seibel P; Schöls L; Kuhn W; Przuntek H
Eur Neurol; 1994; 34(5):263-7. PubMed ID: 7995300
[TBL] [Abstract][Full Text] [Related]
28. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.
Müller-Nedebock AC; Brennan RR; Venter M; Pienaar IS; van der Westhuizen FH; Elson JL; Ross OA; Bardien S
Neurochem Int; 2019 Oct; 129():104495. PubMed ID: 31233840
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
Gu M; Cooper JM; Taanman JW; Schapira AH
Ann Neurol; 1998 Aug; 44(2):177-86. PubMed ID: 9708539
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dysfunction in neurodegenerative disorders.
Schapira AH
Biochim Biophys Acta; 1998 Aug; 1366(1-2):225-33. PubMed ID: 9714816
[TBL] [Abstract][Full Text] [Related]
31. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
Lücking CB; Kösel S; Mehraein P; Graeber MB
Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
[TBL] [Abstract][Full Text] [Related]
32. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.
Palin EJ; Paetau A; Suomalainen A
Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
Schapira AH
Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
[TBL] [Abstract][Full Text] [Related]
34. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
Parker WD; Boyson SJ; Parks JK
Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
[TBL] [Abstract][Full Text] [Related]
35. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
Kösel S; Egensperger R; Schnopp NM; Graeber MB
Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
[TBL] [Abstract][Full Text] [Related]
36. Role of mitochondria in Parkinson disease.
Kösel S; Hofhaus G; Maassen A; Vieregge P; Graeber MB
Biol Chem; 1999; 380(7-8):865-70. PubMed ID: 10494835
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
38. Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect.
Lestienne P; Nelson J; Riederer P; Jellinger K; Reichmann H
J Neurochem; 1990 Nov; 55(5):1810-2. PubMed ID: 2120389
[TBL] [Abstract][Full Text] [Related]
39. [Idiopathic Parkinson disease and mitochondrial functions].
Tranchant C; Weess C; Warter JM
Rev Neurol (Paris); 1995 Mar; 151(3):157-60. PubMed ID: 7676150
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
Hattori N; Tanaka M; Ozawa T; Mizuno Y
Ann Neurol; 1991 Oct; 30(4):563-71. PubMed ID: 1665052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
